Introducing Immune System, Karger’s latest Open Access journal. The new peer-reviewed journal will focus in Immunology with a special attention to Environmental Immunology, Immunomics and Immunotherapy, bridging clinical, preclinical and translational investigations.
Karger Publishers’ new journal Immune System features Open Access-based original research and reviews reporting on translational and clinical studies encompassing all fields of immunology with the intention of bridging clinical research with preclinical and translational investigations. With the launch of this new journal, the company seeks to fulfill a strong need in the scientific community for an open and up-and-coming forum for current basic and applied immunological research. The journal will emphasize evidence-based clinical and laboratory research with statistically valid results that clearly help to advance the future of science.
The world-renowned editors-in-chief, Désirée Larenas-Linnemann, Hospital Medica Sur, Mexico City, Mexico, along with Florent Ginhoux, A*Star, Singapore, are specifically welcoming intra- and interdisciplinary research on Environmental Immunology, Immunomics, Immunotherapy, including but not restricted to immune aspects of allergies, respiratory tract, skin, autoimmune and neurodegenerative disorders. The editors are looking for cutting-edge scientific research, systematic reviews, well-elaborated clinical cases and case-series. The transfer of information from fundamental research to clinical research and clinical practice – that is from lab bench to bed — is particularly welcome.
“Immune System is an innovative Open Access journal, welcoming articles with a broad background from basic science to clinical research, as long as the manuscript focuses on certain aspects of our immune response,” states editor-in-chief Désirée Larenas-Linnemann.
“I’m delighted to announce the launch of our new Karger journal, Immune System, committed to advancing the frontiers of immunology by showcasing and pioneering discoveries that unite clinical and preclinical research. Let’s collaboratively shape a future for immunological research, unbound by limitations” says Marco Casola, Publications Manager of Immunology and Allergy.
Submissions will be accepted on a rolling basis via the journal’s homepage at https://go.karger.com/e/925633/ims/2fpynf/566047611?h=20wEZo1dJKAj7jyRoqRtO17gyGaOiNe19zSFxQ5Mpc4.
